Pradžia › Pjautinio ląstelės anemija › Texas
Pjautinio ląstelės anemija klinikiniai tyrimai Texas
11 tyrimai dėl Pjautinio ląstelės anemija ieško dalyvių vietose Texas.
Miestai Texas
Oficialus tyrimo tekstas (anglų kalba)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Texas Childrens Cancer and Hematology Center, Houston
- U of TX Health Science Ct, Houston
Renkami dalyviai3 fazė
Amžius nuo 12 iki 100 · Visoms lytims · Atnaujinta 2026-09-28 · NCT06439082A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Texas Children's Hospital_Houston, Houston
- UT Health University of Texas, Houston
Renkami dalyviai3 fazė
Amžius 2 ir vyresni · Visoms lytims · Atnaujinta 2026-09-18 · NCT06609226A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- UT Health University of Texas, Houston
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT06612268A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- UT Health Science Center, Houston
Renkami dalyviai1/2 fazėLaukiami sveiki savanoriai
Amžius nuo 12 iki 55 · Visoms lytims · Atnaujinta 2026-09-09 · NCT06546670ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Children's Blood and Cancer Center of Central Texas, Austin
- North Texas Hemophilia and Thrombosis Program - Pediatric Program / Center for Cancer & Blood Disorders, Dallas
- North Texas Comprehensive Hemophilia Treatment Center, Dallas
- ir dar 3
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-08-17 · NCT04398628The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- Baylor College of Medicine- Site Number : 8400055, Houston
Renkami dalyviai3 fazė
Amžius nuo 10 iki 65 · Visoms lytims · Atnaujinta 2026-07-29 · NCT06975865Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Texas Children's Hopsital (NT-DMT), Houston
- Texas Children's Hospital (MRD-HCT), Houston
- UT San Antonio (NT-DMT), San Antonio
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 3 iki 20 · Visoms lytims · Atnaujinta 2026-06-04 · NCT06941389Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease
- Site # 8400004, Houston
Renkami dalyviai3 fazė
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-04-15 · NCT07247188Sickle Cell Kidney Biorepository
- Parkland Memorial Hospital, Dallas
- University of Texas Southwestern Medical Center, Dallas
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-04-13 · NCT07064174Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
- Baylor College of Medicine, Houston
Renkami dalyviai2 fazė
Amžius nuo 15 iki 40 · Visoms lytims · Atnaujinta 2026-03-13 · NCT06260891Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
- University of Texas at Houston, Houston
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-06-22 · NCT06385886Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.